From Therapeutic Drug Monitoring to Model-Informed Precision Dosing: A Review of Busulfan Dosing Optimization in Pediatric Hematopoietic Stem Cell Transplantation
Xiao-Ying Zhang, Yue Li, Jing Xu, Yong-Jun Fang, Xuan-Sheng Ding, Feng Chen · 2026
Read From Therapeutic Drug Monitoring to Model-Informed Precision Dosing: A Review of Busulfan Dosing Optimization in Pediatric Hematopoietic Stem Cell Transplantation by Xiao-Ying Zhang, Yue Li, Jing Xu, Yong-Jun Fang, Xuan-Sheng Ding, Feng Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13610923.txt.
Description
Xiao-Ying Zhang, Yue Li, Jing Xu, Yong-Jun Fang, Xuan-Sheng Ding, and Feng Chen wrote a 2026 review on dosing a chemotherapy drug for children facing stem cell transplants. The drug, busulfan, prepares the body for transplant but has a narrow safe range. Too little risks failure, too much harms organs, and children clear it at very different rates.
The review traces the move from simple blood-level checks to model-informed dosing. In the newer approach, a computer model of the drug in the body, updated with the child's own blood tests, sets each dose. Body size is the main driver of clearance, with age, disease, and genes adding smaller effects. The authors sum up what is known and where dosing tools still fall short.
Catalog record
| CREATOR | Xiao-Ying Zhang, Yue Li, Jing Xu, Yong-Jun Fang, Xuan-Sheng Ding, Feng Chen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |